Expression of VEGF-receptor system in conceptus during peri-implantation period and endometrial and luteal expression of soluble VEGFR-1 in the pig

Theriogenology

Volumn 71, Issue 8, 2009, Pages 1298-1306

  Kaczmarek, M M ^a   Kiewisz, J ^a   Schams, D ^b   Ziecik, A J ^a  

^a INSTITUTE OF ANIMAL REPRODUCTION AND FOOD RESEARCH   (Poland)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Angiogenesis; Conceptus; Reproductive tract; Soluble VEGFR 1; VEGF receptor system

Indexed keywords

VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1;

ANIMAL; ARTICLE; BLASTOCYST; CORPUS LUTEUM; ENDOMETRIUM; FEMALE; GENETICS; LUTEAL CELL; METABOLISM; NIDATION; PREGNANCY; SOLUBILITY; SWINE;

ANIMALS; BLASTOCYST; CORPUS LUTEUM; EMBRYO IMPLANTATION; ENDOMETRIUM; FEMALE; LUTEAL CELLS; PREGNANCY; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SOLUBILITY; SWINE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

SUIDAE; SUS;

EID: 63449127793     PISSN: 0093691X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.theriogenology.2008.12.022     Document Type: Article

References (30)

1. Bazer F.W., Geisert R.D., Thatcher W.W., and Roberts R.M. The establishment and maintenance of pregnancy. In: Cole D.J.A., and Foxcroft G.R. (Eds). Control of pig reproduction (1982), Butterworth Scientific, London 227-253
2. Ford S.P., and Christenson R.K. Blood flow to uteri of sows during the estrous cycle and early pregnancy: local effect of the conceptus on the uterine blood supply. Biol Reprod 21 (1979) 617-624
3. Ford S.P., Reynolds L.P., and Magness R.R. Blood flow to the uterine and ovarian vascular beds of gilts during the estrous cycle or early pregnancy. Biol Reprod 27 (1982) 878-885
4. Enders A.C., Hendrickx A.G., and Schlafke S. Implantation in the rhesus monkey: initial penetration of endometrium. Am J Anat 167 (1983) 275-298
5. Psychoyos A. Endocrine control of egg implantation. In: Greep R.O., Astwood E.G., and Geiger S.R. (Eds). Handbook of physiology (1973), American Physiology Society, Washington 187-215
6. Boshier D.P. The pontamine blue reaction in pregnant sheep uteri. J Reprod Fertil 22 (1970) 595-596
7. Keys J.L., King G.J., and Kennedy T.G. Increased uterine vascular permeability at the time of embryonic attachment in the pig. Biol Reprod 34 (1986) 405-411
8. Keys J.L., and King G.J. Morphological evidence for increased uterine vascular permeability at the time of embryonic attachment in the pig. Biol Reprod 39 (1988) 473-487
9. Dvorak H.F., Brown L.F., Detmar M., and Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146 (1995) 1029-1039
10. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat Med 9 (2003) 669-676
11. Ferrara N., Houck K.A., Jakeman L.B., Winer J., and Leung D.W. The vascular endothelial growth factor family of polypeptides. J Cell Biochem 47 (1991) 211-218
12. Tischer E., Mitchell R., Hartman T., Silva M., Gospodarowicz D., Fiddes J.C., et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266 (1991) 11947-11954
13. Kendall R.L., and Thomas K.A. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 90 (1993) 10705-10709
14. Rabbani M.L., and Rogers P.A. Role of vascular endothelial growth factor in endometrial vascular events before implantation in rats. Reproduction 122 (2001) 85-90
15. Rockwell L.C., Pillai S., Olson C.E., and Koos R.D. Inhibition of vascular endothelial growth factor/vascular permeability factor action blocks estrogen-induced uterine edema and implantation in rodents. Biol Reprod 67 (2002) 1804-1810
16. Kaczmarek M.M., Kowalczyk A.E., Waclawik A., Schams D., and Ziecik A.J. Expression of vascular endothelial growth factor and its receptors in the porcine corpus luteum during the estrous cycle and early pregnancy. Mol Reprod Dev 74 (2007) 730-739
17. Kaczmarek M.M., Waclawik A., Blitek A., Kowalczyk A.E., Schams D., and Ziecik A.J. Expression of the vascular endothelial growth factor-receptor system in the porcine endometrium throughout the estrous cycle and early pregnancy. Mol Reprod Dev 75 (2008) 362-372
18. 2. Mol Cell Endocrinol 291 (2008) 33-41
19. Kaczmarek M.M., Blitek A., Schams D., and Ziecik A.J. The effect of insulin-like growth factor-I, relaxin and luteinizing hormone on vascular endothelial growth factor secretion by cultured endometrial stromal cells on different days of early pregnancy in pigs. Reprod Biol 8 (2008) 163-170
20. Kowalczyk A.E., Kaczmarek M.M., Schams D., and Ziecik A.J. Effect of prostaglandin E2 and tumor necrosis factor α on the VEGF-receptor system expression in cultured porcine luteal cells. Mol Reprod Dev 75 (2008) 1558-1566
21. Dantzer V., and Leiser R. Initial vascularisation in the pig placenta. I. Demonstration of nonglandular areas by histology and corrosion casts. Anat Rec 238 (1994) 177-190
22. Winther H., Ahmed A., and Dantzer V. Immunohistochemical localization of vascular endothelial growth factor (VEGF) and its two specific receptors, Flt-1 and KDR, in the porcine placenta and nonpregnant uterus. Placenta 20 (1999) 35-43
23. Vonnahme K.A., Wilson M.E., and Ford S.P. Relationship between placental vascular endothelial growth factor expression and placental/endometrial vascularity in the pig. Biol Reprod 64 (2001) 1821-1825
24. Halder J.B., Zhao X., Soker S., Paria B.C., Klagsbrun M., Das S.K., et al. Differential expression of VEGF isoforms and VEGF(164)-specific receptor neuropilin-1 in the mouse uterus suggests a role for VEGF(164) in vascular permeability and angiogenesis during implantation. Genesis 26 (2000) 213-224
25. Charnock-Jones D.S., Sharkey A.M., Boocock C.A., Ahmed A., Plevin R., Ferrara N., et al. Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells. Biol Reprod 51 (1994) 524-530
26. Clark D.E., Smith S.K., Sharkey A.M., and Charnock-Jones D.S. Localization of VEGF and expression of its receptors Flt and KDR in human placenta throughout pregnancy. Hum Reprod 11 (1996) 1090-1098
27. Clark D.E., Smith S.K., He Y., Day K.A., Licence D.R., Corps A.N., et al. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod 59 (1998) 1540-1548
28. McKeeman G.C., Ardill J.E., Caldwell C.M., Hunter A.J., and McClure N. Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. Am J Obstet Gynecol 191 (2004) 1240-1246
29. Krüssel J.S., Casañ E.M., Raga F., Hirchenhain J., Wen Y., Huang H.Y., et al. Expression of mRNA for vascular endothelial growth factor transmembraneous receptors Flt1 and KDR, and the soluble receptor sFlt in cycling human endometrium. Mol Hum Reprod 5 (1999) 452-458
30. Christenson R.K., Farley D.B., Anderson L.H., and Ford S.P. Luteal maintenance during early pregnancy in the pig: role for prostaglandin E2. Prostaglandins 47 (1994) 61-75